194 related articles for article (PubMed ID: 32775812)
1. 2018 Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C in Chronic Kidney Disease Guideline Implementation: Asia Summit Conference Report.
Li PK; Bavanandan S; Mohamed R; Szeto CC; Wong VW; Chow KM; Dan YY; Huang CC; Lai CL; Tanwandee T; Teo BW; Wong GL; Yeoh EK; Iseki K; Leung CB; Park HC; Kanjanabuch T; Lu W; Fung J; Jia J; Kanda E; Law MC; Liu H; Loo CK; Mak SK; Lui SL; Tang HL; Wang AY; Yu ML; Cheung M; Jadoul M
Kidney Int Rep; 2020 Aug; 5(8):1129-1138. PubMed ID: 32775812
[TBL] [Abstract][Full Text] [Related]
2. 2017 Kidney Disease: Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update Implementation: Asia Summit Conference Report.
Wang AY; Akizawa T; Bavanandan S; Hamano T; Liew A; Lu KC; Lumlertgul D; Oh KH; Zhao MH; Ka-Shun Fung S; Obi Y; Sumida K; Choong LHL; Goh BL; Hao CM; Kwon YJ; Tarng DC; Zuo L; Wheeler DC; Tsukamoto Y; Fukagawa M
Kidney Int Rep; 2019 Nov; 4(11):1523-1537. PubMed ID: 31890994
[TBL] [Abstract][Full Text] [Related]
3. KDOQI US Commentary on the 2018 KDIGO Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C.
Roth D; Bloom RD; Molnar MZ; Reese PP; Sawinski D; Sise ME; Terrault NA
Am J Kidney Dis; 2020 May; 75(5):665-683. PubMed ID: 32279907
[TBL] [Abstract][Full Text] [Related]
4. Summary of the 2018 Kidney Disease Improving Global Outcomes (KDIGO) Guideline on hepatitis C in chronic kidney disease.
Gordon CE; Balk EM; Francis JM
Semin Dial; 2019 Mar; 32(2):187-195. PubMed ID: 30496617
[TBL] [Abstract][Full Text] [Related]
5. Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice Guideline.
Awan AAY; Berenguer MC; Bruchfeld A; Fabrizi F; Goldberg DS; Jia J; Kamar N; Mohamed R; Pessôa MG; Pol S; Sise ME; Balk EM; Gordon CE; Adam G; Cheung M; Earley A; Martin P; Jadoul M
Ann Intern Med; 2023 Dec; 176(12):1648-1655. PubMed ID: 38079642
[TBL] [Abstract][Full Text] [Related]
6. Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management.
Jadoul M; Berenguer MC; Doss W; Fabrizi F; Izopet J; Jha V; Kamar N; Kasiske BL; Lai CL; Morales JM; Patel PR; Pol S; Silva MO; Balk EM; Gordon CE; Earley A; Di M; Martin P
Kidney Int; 2018 Oct; 94(4):663-673. PubMed ID: 30243313
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C in Chronic Kidney Disease: An Overview of the KDIGO Guideline.
Awan AA; Jadoul M; Martin P
Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2158-2167. PubMed ID: 31376491
[TBL] [Abstract][Full Text] [Related]
8. Executive Summary of the KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease.
Martin P; Awan AA; Berenguer MC; Bruchfeld A; Fabrizi F; Goldberg DS; Jia J; Kamar N; Mohamed R; Pessôa MG; Pol S; Sise ME; Balk EM; Gordon CE; Adam G; Cheung M; Earley A; Jadoul M
Kidney Int; 2022 Dec; 102(6):1228-1237. PubMed ID: 36411019
[TBL] [Abstract][Full Text] [Related]
9. Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline.
Gordon CE; Berenguer MC; Doss W; Fabrizi F; Izopet J; Jha V; Kamar N; Kasiske BL; Lai CL; Morales JM; Patel PR; Pol S; Silva MO; Balk EM; Earley A; Di M; Cheung M; Jadoul M; Martin P
Ann Intern Med; 2019 Oct; 171(7):496-504. PubMed ID: 31546256
[TBL] [Abstract][Full Text] [Related]
10. KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).
Isakova T; Nickolas TL; Denburg M; Yarlagadda S; Weiner DE; Gutiérrez OM; Bansal V; Rosas SE; Nigwekar S; Yee J; Kramer H
Am J Kidney Dis; 2017 Dec; 70(6):737-751. PubMed ID: 28941764
[TBL] [Abstract][Full Text] [Related]
11. KDOQI US commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD.
Sarnak MJ; Bloom R; Muntner P; Rahman M; Saland JM; Wilson PW; Fried L
Am J Kidney Dis; 2015 Mar; 65(3):354-66. PubMed ID: 25465166
[TBL] [Abstract][Full Text] [Related]
12. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.
Inker LA; Astor BC; Fox CH; Isakova T; Lash JP; Peralta CA; Kurella Tamura M; Feldman HI
Am J Kidney Dis; 2014 May; 63(5):713-35. PubMed ID: 24647050
[TBL] [Abstract][Full Text] [Related]
13. Anemia Management in Peritoneal Dialysis: Perspectives From the Asia Pacific Region.
Li PKT; Choy ASM; Bavanandan S; Chen W; Foo M; Kanjanabuch T; Kim YL; Nakayama M; Yu X
Kidney Med; 2021; 3(3):405-411. PubMed ID: 34136787
[TBL] [Abstract][Full Text] [Related]
14. KDOQI US commentary on the KDIGO clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in CKD.
Gordon CE; Balk EM; Becker BN; Crooks PA; Jaber BL; Johnson CA; Michael MA; Pereira BJ; Uhlig K; Levin A
Am J Kidney Dis; 2008 Nov; 52(5):811-25. PubMed ID: 18971009
[TBL] [Abstract][Full Text] [Related]
15. Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns.
Levin A; Ahmed SB; Carrero JJ; Foster B; Francis A; Hall RK; Herrington WG; Hill G; Inker LA; Kazancıoğlu R; Lamb E; Lin P; Madero M; McIntyre N; Morrow K; Roberts G; Sabanayagam D; Schaeffner E; Shlipak M; Shroff R; Tangri N; Thanachayanont T; Ulasi I; Wong G; Yang CW; Zhang L; Robinson KA; Wilson L; Wilson RF; Kasiske BL; Cheung M; Earley A; Stevens PE
Kidney Int; 2024 Apr; 105(4):684-701. PubMed ID: 38519239
[TBL] [Abstract][Full Text] [Related]
16. Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data.
Johnson DW; Dent H; Yao Q; Tranaeus A; Huang CC; Han DS; Jha V; Wang T; Kawaguchi Y; Qian J
Nephrol Dial Transplant; 2009 May; 24(5):1598-603. PubMed ID: 19096083
[TBL] [Abstract][Full Text] [Related]
17. Adaptation and implementation of the "Kidney Disease: Improving Global Outcomes (KDIGO)" guidelines for evaluation and management of mineral and bone disorders in chronic kidney disease for practice in the Middle East countries.
Al Rukhaimi M; Al Sahow A; Boobes Y; Goldsmith D; Khabouth J; El Baz T; Mahmoud H; Ganji MR; Shaheen FA;
Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):133-48. PubMed ID: 24434398
[TBL] [Abstract][Full Text] [Related]
18. Indian commentary on the 2009 KDIGO clinical practice guideline for the diagnosis, evaluation, and treatment of chronic kidney disease-mineral and bone disorders.
Jha V; Kher V; Pisharody R; Sharma RK; Abraham G; Gokulnath ; Almeida A; Gupta A
Indian J Nephrol; 2011 Jul; 21(3):143-51. PubMed ID: 21886971
[TBL] [Abstract][Full Text] [Related]
19. Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Cheung AK; Chang TI; Cushman WC; Furth SL; Ix JH; Pecoits-Filho R; Perkovic V; Sarnak MJ; Tobe SW; Tomson CRV; Cheung M; Wheeler DC; Winkelmayer WC; Mann JFE;
Kidney Int; 2019 May; 95(5):1027-1036. PubMed ID: 31010478
[TBL] [Abstract][Full Text] [Related]
20. Revisiting KDIGO clinical practice guideline on chronic kidney disease-mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conference.
Ketteler M; Elder GJ; Evenepoel P; Ix JH; Jamal SA; Lafage-Proust MH; Shroff R; Thadhani RI; Tonelli MA; Kasiske BL; Wheeler DC; Leonard MB
Kidney Int; 2015 Mar; 87(3):502-28. PubMed ID: 25651364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
